For many MedTech companies, regulatory is treated as a late-stage compliance hurdle. In reality, it is one of the most critical drivers of development timelines, investment readiness, and market success.
This session will provide a practical, insider perspective on how regulatory strategy under UK and EU MDR frameworks directly impacts product development, clinical planning, and commercial outcomes. Drawing on experience from within a Notified Body, the talk will highlight the most common reasons submissions are delayed or rejected, and what differentiates companies that progress efficiently.
Attendees will gain clear, actionable insight into the strategic decisions that shape regulatory success, including defining intended purpose, aligning clinical and design strategies, managing risk effectively, and engaging with Notified Bodies at the right time.

This is not a technical deep dive into regulations, but a focused session on how to use regulatory strategy as a lever to accelerate development, reduce risk, and strengthen investor confidence.